Hyderabad-based Laurus Labs’ net profit remained flat ₹48.8 crore in Q2 FY18, compared to ₹48.3 crore in Q2 FY17. The total revenue of company grew 4.3 per cent at Rs 538 crore (Rs 516 crore).
Pfizer’s offer for the San Francisco, California-based Medivation goes far beyond the company’s market value of $11.1 billion. Medivation shares closed at $67.16 in Friday trading (Reuters)